Pfizer-Biotech Seek EU Covid-19 Vaccine Approval For Children

Published Apr 30 2021 at 5:21 PM GMT
  • Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies' coronavirus vaccine to include children aged 12 to 15.
  • The move could offer younger and less at-risk populations in Europe access to the shots for the first time.
  • In a statement on Friday, the two companies.



  • Published Apr 30, 2021 5:21 PM GMT